Search Results

Monserrat Avila Zozaya on the web LinkedIn Antony Boucard Lab Dr. John Azietaku on the web LinkedIn Dr. GPCR About Ya-Tzu Li Ya-Tzu is a Master's student at the University of South Florida, utilizing large-scale In August, Ya-Tzu will continue her academic and research pursuits by beginning her PhD training in Medical Ya-Tzu Li on the web LinkedIn Dr.

GPCR Podcast << Back to podcast list Dr. Nicolas Gilles About Dr. Nicolas Gilles "Dr. His strongest expertise lies in therapeutic target identification and all the steps from venom manipulations When the pharmacological properties of these new ligands are deemed exceptional, a lead optimization Nicolas Gilles on the web Google Scholar LinkedIn Dr. GPCR Enjoying the Dr. GPCR Podcast? : The pHSense Revolution How a Failed Med School Dream Sparked a GPCR Biotech Revolution Thanks for listening

For decades, molecular modeling focused on explaining — rationalizing why a ligand binds, why a mutation With tools like AlphaFold , his lab can now model receptor–peptide complexes in seconds — an achievement A good model doesn’t just match published structures; it forecasts new biology, new ligands, and new That’s where the future of GPCR research lies — not in describing the past, but in anticipating it.

Rottapel’s research interests lies in the elucidation of signal transduction pathways in cancer, immune The Rottapel Lab Ontario Institute for Cancer Research University of Toronto Pubmed Google Scholar LinkedIn

GPCR Podcast << Back to podcast list Dr. Robert J. His legacy lies in the numerous discoveries he and his team made in the GPCR field and in all those who : The pHSense Revolution How a Failed Med School Dream Sparked a GPCR Biotech Revolution Thanks for listening

Abhishek Kumar Singh Investigating The Role of ADGRB3 Loss of Expression in Brain Tumor Formation in Li-Fraumeni Scholar X (Twitter) Investigating The Role of ADGRB3 Loss of Expression in Brain Tumor Formation in Li-Fraumeni Syndrome Alex Torrelli-Diljohn Abstract "Li-Fraumeni syndrome (LFS) is a rare cancer predisposition Authors & Affiliations "Vukadin L, Park B, Mohamed M, Li H, Elkholy A, Torrelli-Diljohn A, Kim JH, Jeong He is interested in working on Li-Fraumeni syndrome and helping patients afflicted with this condition

Back to schedule Trainee Symposium II Date & Time Thursday, November 2nd / 3:00 PM - 4:00 PM Title: Linking My primary research focus lies in gaining deeper insights into the structural mechanisms governing G protein engineering, receptor pharmacology, and structural biology to study how different types of ligands

2,3,*, Analisa Thompson Gray 2, Feyisayo Adegboye 2, Ainsley McDonald-Boyer 3, Fubiao Shi 1, Dianxin Liu 1, Jose Maldonado 5, Jiesi Feng 4, Yulong Li 4, Simon Alford 5, Julio E. The Department’s strengths lie in GPCR signal transduction and neuroscience, and she has expanded it She gave the Fritz Lipmann Lecture at ASBMB in 2001. " Heidi Hamm on the web The Hamm Lab Vanderbilt School of Medicine Pubmed Google Scholar LinkedIn Twitter Dr.

GPCR Podcast << Back to podcast list From Rare Earth Probes to Internalization Assays: The pHSense Story the IP-One kit, Tag-lite, and now, pH Sense. HTRF, the IP-One kit, and the Tag-lite platform into widespread use. His passion lies in turning cutting-edge probe chemistry into robust, scalable tools for drug discovery GPCR X Revvity Collaboration ⸻ Want more like this? Join the Dr.

GPCR Podcast << Back to podcast list From Curiosity to Breakthrough: Ajay Yekkirala on GPCR Innovation What if the key to safer, more effective drugs lies in asking the right questions — and daring to challenge is the heart of scientific innovation Who Should Listen PhD students and postdocs exploring biotech careers Seeing the limits of traditional drug discovery, he later co-founded Superluminal Medicines, a company Ajay Yekkirala on the web Superluminal Medicines LinkedIn Tune in now to hear how asking “what if?”

species, we plan to adapt this technology for high-throughput screening of pharmacological compound libraries Stephanie Häfner on the web LinkedIn Scholz Lab Langenhan Lab bioSens-All: A Multiparametric BRET-Based Authors & Affiliations "Ana Lilia Moreno Salinas (2), Arturo Mancini (1), Raida Jallouli (2), Richard My expertise lies in exploring the biological properties and signaling pathways activated by aGPCRs, Ana Lilia Moreno Salinas on the web ResearchGate LinkedIn < Previous Session Next Session >

< Back to Full Agenda Session II AGPCR signaling pathways and trafficking Localization of putative ligands ADGRG6 Drives Proteolytic Processing, Trafficking And Signalling Pal Kasturi Localization of putative ligands Yuling Feng on the web LinkedIn The ADGRF5/GPR116 receptor is a key regulator of lymphatic endothelial His research interest lies in understanding the molecular basis for human tumor development and how to ADGRG6 NTF has multiple extracellular domains like CUB, PTX, SEA, hormone binding domain, and the GAIN

Email us if you'd like to teach or if you'd like to learn more about any particular topic. 🗓️ Upcoming 4-Week Course: Development of GPCR Ligands as Therapeutic Drugs starting March 20 – April 10, 2025 ( Highlights of the Week How Ligands Achieve Biased Signaling toward Arrestins Stéphanie Gaillard , Neha A combined in silico approach to design peptide ligands with increased receptor-subtype selectivity Adam type-dependent involvement of Gi, Gq, Gs proteins and protein kinase C Qin Wang , Wenwen Hao , Jing Li

🎧 Listen now: Ep 165 with Chuck DeWeese & Joe St. 🎧 Listen now: Ep 165 with Chuck DeWeese & Joe St.

. ✳️ Listen now: Ep 167 with Drs. Big win for the GPCR community. ✳️ Listen now: Ep 167 with Drs.

. ✅ Comprehensive course library covering cutting-edge GPCR science ✅ Practical insights for real-world offers industry-focused courses designed to help you stay ahead in the field. ✅ Comprehensive course library

In neuronal cell lines, the use of Gαi bONE-GO revealed that several natural opioid neuropeptides act In neuronal cell lines, the use of Gαi bONE-GO revealed that several natural opioid neuropeptides act

Then, with Celtarys, the team did the same for ligand-linker-fluorophore chemistry. Then, with Celtarys, the team did the same for ligand-linker-fluorophore chemistry.

Check out the development of a NanoBRET assay platform to detect intracellular ligands for the chemokine Check out the development of a NanoBRET assay platform to detect intracellular ligands for the chemokine methods-and-updates-in-gpcr-research/development-of-a-nanobret-assay-platform-to-detect-intracellular-ligands-for-the-chemokine-receptors-ccr6

If you’re passionate about GPCRs and drug discovery, this episode is a must-listen! ✳️Listen at Ep 163 with Dr. If you’re passionate about GPCRs and drug discovery, this episode is a must-listen! ✳️Listen at Ep 163 with Dr.

Listen to other scientists’ research—it’s a great way to stay motivated and inspired 🚀 Don’t miss this Listen to other scientists’ research—it’s a great way to stay motivated and inspired 🚀 Don’t miss this They’re kinetic game-changers—compounds that rewrite the relationship between ligand, receptor, and physiologic ago Enzyme Inhibition Pharmacology: The Hidden Gatekeepers of GPCR Drug Discovery Before your GPCR ligand Your GPCR Drug Discovery Power Lever If you want cleaner decisions, start with the system—then the ligand

structural-and-molecular-insights-into-gpcr-function/cryo-em-reveals-cholesterol-binding-in-the-lysosomal-gpcr-like-protein-lychos structural-and-molecular-insights-into-gpcr-function/cryo-em-reveals-cholesterol-binding-in-the-lysosomal-gpcr-like-protein-lychos

🎙️ Listen now https://buff.ly/fYZ1tSq #DrGPCR #GPCR #DrugDiscovery #Pharma #Biotech #SciencePodcast 🎙️ Listen now https://buff.ly/fYZ1tSq #DrGPCR #GPCR #DrugDiscovery #Pharma #Biotech #SciencePodcast

Terry Kenakin, “Development of GPCR Ligands as Therapeutic Drugs” is coming up 🧐 Be the first to register ✳️Go to https://www.ecosystem.drgpcr.com/event-details-registration/development-of-gpcr-ligands-as-therapeutic-drugs Terry Kenakin, “Development of GPCR Ligands as Therapeutic Drugs” is coming up 🧐 Be the first to register ✳️Go to https://www.ecosystem.drgpcr.com/event-details-registration/development-of-gpcr-ligands-as-therapeutic-drugs

New research sheds light on these pathways! ✨ Want to learn more? New research sheds light on these pathways! ✨ Want to learn more?

✅Listen now https://buff.ly/aEQGUFl #gpcr #drgpcr Published on March 17, 2025 Category Dr. ✅Listen now https://buff.ly/aEQGUFl #gpcr #drgpcr Recent Articles Previous Next

Expand your GPCR expertise with exclusive workshops, interactive courses, and an on-demand library—all 🔗 https://www.ecosystem.drgpcr.com/gpcr-courses #GPCR #DrGPCR #LifelongLearning #drugdiscovery #pharmacology Expand your GPCR expertise with exclusive workshops, interactive courses, and an on-demand library—all 🔗 https://www.ecosystem.drgpcr.com/gpcr-courses #GPCR #DrGPCR #LifelongLearning #drugdiscovery #pharmacology

Tom Sakmar & Ilana Kotliar break down the link between GPCR autoantibodies, long COVID, and disease signaling in Ep.167 of the Dr.GPCR Podcast This episode is a must if you're thinking diagnostics. 📲 Tap to listen Tom Sakmar & Ilana Kotliar break down the link between GPCR autoantibodies, long COVID, and disease signaling in Ep.167 of the Dr.GPCR Podcast This episode is a must if you're thinking diagnostics. 📲 Tap to listen

Home → Flash News → "Solving financial puzzles feels just like solving scientific ones," says Joe St. GPCR Podcast "Solving financial puzzles feels just like solving scientific ones," says Joe St.

announce our strategic partnership with Celtarys Research, a biotech company specializing in fluorescent ligand with Celtarys’ innovative chemical biology tools, making it easier than ever for scientists to study ligand-receptor announce our strategic partnership with Celtarys Research , a biotech company specializing in fluorescent ligand with Celtarys’ innovative chemical biology tools , making it easier than ever for scientists to study ligand-receptor